BPA Call HT942523A0016-HT009024FG0710030
Award Date
7/18/24
Potential Completion Date
9/30/24
Potential Value
$23K
Federal Agency
Defense Health Agency
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The $391,916.36 contract is for the supply of reagents and consumables, with a period of performance through July 12, 2024. Qiagen has provided similar products and services to federal agencies in the past, including for biomedical research, public health, and healthcare programs. The contract award is not...
This is a firm fixed-price BPA call contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $156,764.92 ceiling value contract is for the supply of reagents and consumables, with a performance period ending on March 18, 2025. Qiagen, headquartered in Germantown, Maryland, has an extensive history of providing prime and subcontract goods and services to federal agencies like the National...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and genomic testing solutions. The contract, valued at $29,939.02, is for the provision of reagents and consumables. It has a performance period extending until April 11, 2025. Qiagen has an extensive portfolio of federal contracts and Indefinite Delivery Vehicles (IDVs) with agencies such as the FBI, Department of...
This federal contract award is for the delivery of controls, reagents, and consumables from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $202,026.53 firm-fixed-price delivery order was awarded by the Defense Health Agency (DHA) and is not set aside for any special designations. Qiagen is an experienced federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with agencies such as the Department of...
This is a federal contract award from the Defense Health Agency (DHA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $68,938.86 contract is a firm fixed-price Blanket Purchase Agreement (BPA) call for the provision of reagents and consumables. The contract has no set-aside designation and runs through February 2025. Qiagen, headquartered in Germantown, Maryland, is an experienced federal contractor supporting multiple government...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
The Defense Health Agency awarded Qiagen Sciences LLC, a subsidiary of Qiagen N.V., a $11,310.40 firm fixed-price purchase order for the delivery of Deoxyribonucleic Acid (DNA) Organ Transplant Kits. This award was issued on December 27, 2023, with a final completion date of August 19, 2024. The contract has no set-aside designation, indicating Qiagen Sciences LLC was selected as the prime contractor without a preference for small businesses or other socioeconomic categories. Qiagen Sciences LLC...